e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Atea Pharmaceuticals, Inc. - common stock (NQ:AVIR)

4.855 +0.235 (+5.09%)

Streaming Delayed Price Updated: 12:21 PM EDT, Jul 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atea Pharmaceuticals, Inc. - common stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Was Atea Pharmaceutical's Flop Predictable? ↗

October 26, 2021

Were warning signs there for investors all along?

Via The Motley Fool

How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More ↗

October 25, 2021

Last week, the five biggest stock market losers declined between about 75% and 37%. Below is a look at each stock and what they may have in the cards going forward. Galera...

Via Benzinga

Why Atea Pharmaceuticals Stock Got Crushed This Week ↗

October 22, 2021

A mid-stage trial miss caused investors to hit the exits this week.

Via The Motley Fool

Expert Ratings For Atea Pharmaceuticals ↗

October 20, 2021

Over the past 3 months, 5 analysts have published their opinion on Atea Pharmaceuticals (NASDAQ:

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

October 20, 2021

Mizuho cut QUALCOMM Incorporated (NASDAQ: QCOM) price target from $180 to $165. QUALCOMM shares fell 0.3% to $132.13 in pre-market trading. Deutsche Bank raised the price...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021 ↗

October 20, 2021

Upgrades For Iridium Communications Inc (NASDAQ:IRD...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher ↗

October 19, 2021

Toward the end of trading Tuesday, the Dow traded up 0.33% to 35,374.03 while the NASDAQ rose 0.54% to 15,103.67. The S&P also rose, gaining 0.55% to 4,511.35. The U.S. has...

Via Benzinga

Topics Stocks

52 Biggest Movers From Yesterday ↗

October 20, 2021

Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares climbed 42.6% to close at $9.51 on Tuesday. Xiaobai Maimai said Xiaobao An resigned as CEO. Kaival Brands Innovations Group...

Via Benzinga

Why Ulta and Atea Rained on the Nasdaq's Parade Tuesday ↗

October 19, 2021

Even with downward pressure from these two stocks, the Nasdaq Composite moved higher again.

Via The Motley Fool

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 19, 2021

Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 18.27% to $5.76 during Tuesday's regular session. Redhill Biopharma's stock is trading at a volume of 2....

Via Benzinga

Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge ↗

October 19, 2021

Midway through trading Tuesday, the Dow traded up 0.47% to 35,423.05 while the NASDAQ rose 0.59% to 15,110.79. The S&P also rose, gaining 0.61% to 4,513.69. The U.S. has the...

Via Benzinga

Topics Stocks

Why Atea Pharmaceuticals Is Imploding Today ↗

October 19, 2021

The company's oral COVID-19 treatment looks like a dud in the mild-to-moderate COVID-19 setting.

Via The Motley Fool

AVIR Stock: The Oral Covid-19 Therapy News That Has Atea Pharmaceuticals Plunging Today ↗

October 19, 2021

Atea Pharmaceuticals (AVIR) stock is on the move Tuesday after providing an update from its Phase 2 Moonsong clinical trial update.

Via InvestorPlace

Atea Pharma Stock Crashes After Merck-Rivaling Covid Pill Lags In Midstage Test ↗

October 19, 2021

Atea Pharmaceuticals said its Covid pill didn't lower viral loads in all patients.

Via Investor's Business Daily

Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance ↗

October 19, 2021

Following the market opening Tuesday, the Dow traded up 0.29% to 35,361.89 while the NASDAQ rose 0.31% to 15,068.75. The S&P also rose, gaining 0.39% to 4,503.81. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 19, 2021

Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market session. The company's market cap stands at $...

Via Benzinga

Why Are Atea Pharmaceuticals Shares Plunging Today? ↗

October 19, 2021

Atea Pharmaceuticals Inc (NASDAQ: AVIR) has reported data from the Phase 2 MOONSONG trial of AT-527 in the outpatient setting in patients with mild or moderate...

Via Benzinga

Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage ↗

October 18, 2021

Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral...

Via Talk Markets

The Next Challenge For Covid Stocks Is Also A Cash Cow For These Companies ↗

October 15, 2021

Companies working on sorely needed Covid treatments are innovating to keep up.

Via Investor's Business Daily

3 COVID Stocks That Can Turn $1,000 Into $10,000 ↗

October 12, 2021

Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic.

Via The Motley Fool

Molnupiravir? Not So Fast. What About Tollovir? — Here's Why You Should Know What That Means ↗

October 12, 2021

Photo by Martin Sanchez on Unsplash Merck (NYSE: MRK) announced last Friday impressive results from its COVID-19 antiviral, molnupiravir. As vaccines are requiring a third booster...

Via Benzinga

10 Health Care Stocks With Unusual Options Alerts In Today's Session ↗

October 08, 2021

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option...

Via Benzinga

Which COVID-19 Pill Stock Is the Best Buy? ↗

October 05, 2021

Merck, Pfizer, and Atea are set to do battle next year in the COVID-19 pill market.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021 ↗

October 05, 2021

Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ:

Via Benzinga

3 Stocks That Might Soar With Pills for COVID ↗

October 03, 2021

Are we seeing a major shift into oral medications for COVID? Our Foolish roundtable picks three of the strongest stocks in this rising subsector.

Via The Motley Fool

Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher ↗

October 01, 2021

Toward the end of trading Friday, the Dow traded up 1.49% to 34,346.53 while the NASDAQ rose 0.75% to 14,556.92. The S&P also rose, gaining 1.18% to 4,358.52. The U.S. has the...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 01, 2021

Gainers Biomerica (NASDAQ:BMRA) stock moved upwards by 39.33% to $6.27 during Friday's regular session. As of 12:30 EST, Biomerica's stock is trading at a volume...

Via Benzinga

Mid-Day Market Update: Dow Surges 300 Points; Omeros Shares Plummet ↗

October 01, 2021

Midway through trading Friday, the Dow traded up 0.88% to 34,141.74 while the NASDAQ rose 0.12% to 14,465.49. The S&P also rose, gaining 0.58% to 4,332.44. The U.S. has the...

Via Benzinga

Topics Stocks

Why Atea Pharmaceutical Stock Is Ripping Higher Today ↗

October 01, 2021

This biotech's experimental COVID-19 medication could be a big winner.

Via The Motley Fool

Mid-Morning Market Update: Markets Mostly Higher; ISM Manufacturing Index Rises In September ↗

October 01, 2021

Following the market opening Friday, the Dow traded up 0.49% to 34,010.27 while the NASDAQ fell 0.23% to 14,415.00. The S&P also rose, gaining 0.16% to 4,314.50. The U.S. has...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy